ReviewDermatology and therapy2023

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status.

Thomas B Casale et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.